|
|
|
Investment Objective/Strategy - The Fund's investment objective is to seek to provide investors with long term total return. The Fund intends to pursue its investment objective by establishing long and short positions in a portfolio of Equity Securities.
There can be no assurance that the Fund's investment objectives will be achieved.
Ticker | FTLS |
Fund Type | U.S. Equity |
Investment Advisor | First Trust Advisors L.P. |
Investor Servicing Agent | Bank of New York Mellon Corp |
CUSIP | 33739P103 |
ISIN | US33739P1030 |
Intraday NAV | FTLSIV |
Fiscal Year-End | 10/31 |
Exchange | NYSE Arca |
Inception | 9/8/2014 |
Inception Price | $30.00 |
Inception NAV | $30.00 |
Management Fees | 0.95% |
Other Expenses | 0.51% |
Total Annual Expenses | 1.46% |
As of Date 3/1/2024
"Other Expenses" consist of margin interest expense and dividend expense on investments sold short.
Closing NAV1 | $60.05 |
Closing Market Price2 | $60.17 |
Bid/Ask Midpoint | $60.13 |
Bid/Ask Premium | 0.13% |
30-Day Median Bid/Ask Spread (as of 4/25/2024)3 | 0.21% |
Total Net Assets | $1,161,951,846 |
Outstanding Shares | 19,350,002 |
Daily Volume | 60,027 |
Average 30-Day Daily Volume | 142,546 |
Closing Market Price 52-Week High/Low | $61.66 / $50.84 |
Closing NAV 52-Week High/Low | $61.51 / $50.80 |
Number of Holdings (excluding cash) | 542 |
Maximum Market Cap. | $3,126,133 |
Median Market Cap. | $9,763 |
Minimum Market Cap. | $193 |
Price/Earnings | 18.10 |
Price/Book | 3.22 |
Price/Cash Flow | 12.66 |
Price/Sales | 1.73 |
Maximum Market Cap. | $559,854 |
Median Market Cap. | $14,225 |
Minimum Market Cap. | $1,152 |
Price/Earnings | 24.29 |
Price/Book | 2.79 |
Price/Cash Flow | 13.94 |
Price/Sales | 1.97 |
Holding |
Percent |
Microsoft Corporation |
4.00% |
NVIDIA Corporation |
3.52% |
Apple Inc. |
3.20% |
Amazon.com, Inc. |
2.14% |
Citigroup Inc. |
2.03% |
Starbucks Corporation |
1.78% |
AbbVie Inc. |
1.63% |
Bristol-Myers Squibb Company |
1.54% |
Gilead Sciences, Inc. |
1.45% |
Microchip Technology Incorporated |
1.36% |
*Â Excluding cash.Â
Holdings are subject to change.
Holding |
Percent |
PepsiCo, Inc. |
-0.55% |
Texas Instruments Incorporated |
-0.52% |
Thermo Fisher Scientific Inc. |
-0.48% |
Verizon Communications Inc. |
-0.46% |
Oracle Corporation |
-0.45% |
The Boeing Company |
-0.44% |
Humana Inc. |
-0.42% |
T-Mobile US, Inc. |
-0.41% |
Marvell Technology, Inc. |
-0.40% |
RTX Corporation |
-0.40% |
*Â Excluding cash.Â
Holdings are subject to change.
Past performance is not indicative of future results.
Among 154 funds in the Long-Short Equity category. This fund was rated 4 stars/154 funds (3 years), 4 stars/137 funds (5 years) based on risk adjusted returns.
Long Exposure | 92.61% |
Short Exposure | -34.41% |
Net Exposure | 58.20% |
|
Percent |
Information Technology |
19.71% |
Consumer Discretionary |
17.22% |
Health Care |
11.41% |
Financials |
10.74% |
Communication Services |
9.42% |
Industrials |
8.52% |
Energy |
6.65% |
Materials |
4.20% |
Consumer Staples |
2.66% |
Utilities |
0.49% |
Real Estate |
0.32% |
|
Percent |
Information Technology |
-4.88% |
Industrials |
-4.35% |
Health Care |
-3.20% |
Real Estate |
-2.40% |
Financials |
-2.07% |
Consumer Staples |
-1.99% |
Consumer Discretionary |
-1.84% |
Communication Services |
-1.67% |
Utilities |
-1.31% |
Materials |
-1.30% |
Energy |
-0.74% |
|
2023 |
Q1 2024 |
Q2 2024 |
Q3 2024 |
Days Traded at Premium |
187 |
48 |
17 |
--- |
Days Traded at Discount |
63 |
13 |
3 |
--- |
|
Standard Deviation |
Alpha |
Beta |
Sharpe Ratio |
Correlation |
FTLS |
9.48% |
3.87 |
0.50 |
0.94 |
0.94 |
S&P 500® Index |
17.60% |
--- |
1.00 |
0.56 |
1.00 |
Standard Deviation is a measure of price variability (risk). Alpha is an indication of how much an investment outperforms or underperforms
on a risk-adjusted basis relative to its benchmark.Beta is a measure of price variability relative to the market. Sharpe Ratio is a measure
of excess reward per unit of volatility. Correlation is a measure of the similarity of performance.
S&P 500® Index - The Index is an unmanaged index of 500 companies used to measure large-cap U.S. stock market performance.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|